Lexington, MA - March 29, 2006 - Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule drugs to treat severe medical conditions, today announced that the company has been selected to present at the "Future Leaders in the Biotech Industry" conference sponsored by BioCentury and Thomson Financial.

Safi Bahcall, Ph.D., president and chief executive officer of Synta, will provide an overview of the company and its programs. The presentation will take place at 4:00 p.m. on Thursday, March 30, in Room 404/405 at the Millennium Broadway Hotel & Conference Center in New York City. A breakout session will follow.

About Synta

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule drugs to extend and enhance the lives of patients with severe medical conditions, including chronic inflammatory disease and cancer. Synta currently has three drug candidates in human clinical trials, as well as a diverse pipeline of internally developed discovery programs. For more information, see http://www.syntapharma.com/.